亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Breast-conserving surgery with immediate partial breast reconstruction by using pedicled thoracodorsal artery perforator flap: a 7-year follow-up of 50 women

医学 胸背动脉 乳房再造术 外科 普通外科 乳腺癌 自由襟翼 内科学 癌症
作者
Xing Wang,Ling Huo,Yingjian He,Jinfeng Li,Tianfeng Wang,Zhaoqing Fan,Tao Ouyang
出处
期刊:Breast Care [Karger Publishers]
卷期号:: 1-9
标识
DOI:10.1159/000541340
摘要

Introduction: Thoracodorsal artery perforator (TDAP) flap has been used for more than 10 years in the immediate partial breast reconstruction (IPBR) of breast cancer, allowing many patients to maximize reserved autologous breast tissue who do not have indications for breast-conserving surgery (BCS). No large sample size survival data for this operation have been reported worldwide. Methods: There are 212 primary breast cancer patients who were prepared to receive BCS with IPBR of pedicled TDAP flaps in our institution from June 2013 to December 2017. Finally, the operations were completed successfully in 50 cases. All patients were female with a median age of 40 years. Results: The average diameter of TDAPs measured by Doppler ultrasound before the operation was 1.8 ± 0.6 mm (ranging from 0.6 to 3.3 mm). The average size of the flaps was 15 × 6 cm. The average time of operations was 282 ± 71 min (ranging from 120 to 425 min). The drainage tube was removed 4.8 ± 1.9 days after the operation (ranging from 3 to 12 days). All TDAP flaps survived, and the wound complication rate was 4% (2/50). The median follow-up time was 88 (67, 94) months (M [IQR]), with a 5-year ipsilateral breast tumor recurrence rate of 4% (95% CI: 0.1–9.5%), a 5-year breast cancer-free interval of 88.0% (95% CI: 79.0–97.0%), and a 5-year overall survival rate of 96.0% (95% CI: 90.5–99.9%). Conclusion: IPBR using pedicled TDAP flaps is a good choice for repairing local breast defects in BCS. The advantages of this surgery are no influence on latissimus dorsi function, few complications in the donor area, and good long-term prognosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Kao应助科研通管家采纳,获得10
4秒前
Kao应助科研通管家采纳,获得10
4秒前
Kao应助科研通管家采纳,获得10
5秒前
Akim应助月亮姥姥采纳,获得10
25秒前
Criminology34应助月亮姥姥采纳,获得10
25秒前
冷酷的冬莲完成签到,获得积分20
1分钟前
1分钟前
xiaoqingnian完成签到,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
2分钟前
无花果应助yyy采纳,获得10
2分钟前
2分钟前
yyy发布了新的文献求助10
2分钟前
yyy完成签到,获得积分20
2分钟前
3分钟前
Kao应助科研通管家采纳,获得10
4分钟前
彭于晏应助科研通管家采纳,获得10
4分钟前
欣喜的香菱完成签到 ,获得积分10
4分钟前
4分钟前
zz发布了新的文献求助10
4分钟前
尊敬的吐司完成签到,获得积分10
4分钟前
桐桐应助zz采纳,获得10
4分钟前
corleeang完成签到 ,获得积分10
4分钟前
蛋堡完成签到 ,获得积分10
4分钟前
4分钟前
spotlight发布了新的文献求助10
5分钟前
nav完成签到 ,获得积分10
5分钟前
5分钟前
6分钟前
Kao应助科研通管家采纳,获得10
6分钟前
随缘来一个吧完成签到 ,获得积分10
6分钟前
6分钟前
spotlight完成签到,获得积分10
6分钟前
Sunny发布了新的文献求助10
6分钟前
6分钟前
yygz0703完成签到 ,获得积分10
6分钟前
悠木完成签到 ,获得积分10
7分钟前
doudou完成签到 ,获得积分10
7分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cronologia da história de Macau 5000
Petrology and Plate Tectonics 800
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
Handbook Of Synthetic Methodologies And Protocols Of Nanomaterials 500
Trees of tropical Asia : an illustrated guide to diversity 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 光电子学 物理化学 电极 基因 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 6986979
求助须知:如何正确求助?哪些是违规求助? 8664686
关于积分的说明 18370293
捐赠科研通 6454435
什么是DOI,文献DOI怎么找? 3095597
关于科研通互助平台的介绍 2154653
邀请新用户注册赠送积分活动 2071824